NRx Pharmaceuticals (NRXP)
(Delayed Data from NSDQ)
$2.33 USD
0.00 (0.00%)
Updated Jul 19, 2024 04:00 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NRXP 2.33 0.00(0.00%)
Will NRXP be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for NRXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NRXP
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors
NRXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
NRx Pharmaceuticals (NRXP) Upgraded to Strong Buy: Here's What You Should Know
New Strong Buy Stocks for April 4th
Pick These Top-Ranked Stocks to Deck Up Your Christmas Tree
Other News for NRXP
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing
NRx Pharmaceuticals to proceed with two new NDAs in 2024
NRX Pharmaceuticals Faces Agreement Termination, Eyes Accelerated Approval
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors